Skip to main content
. 2010 Jul 2;17(11):771–779. doi: 10.1038/cgt.2010.34

Figure 6.

Figure 6

Ad.IL-24-Bax suppressed the proliferation of hepatocellular carcinoma cells and induced apoptosis in hepatocellular carcinoma in vivo. (a) The treatment was performed every 3 days for a total of three times for each mouse (n=5) and killed the mice after 3 weeks. Expression of ki-67 in Hep3B tumors was analyzed by immunohistochemistry 3 weeks after the initial injection of transgenic virus, and apoptotic Hep3B cells were detected by transferase-mediated dUTP nick-end-labeling. (b) The number of positive cells was counted as described in Materials and methods. *P<0.05, vs the Ad.Luc group. #P<0.05 vs the Ad.IL-24 group. The results were expressed as means±s.d. of three randomly selected mice.